This compound is a modified nucleoside used as a building block in oligonucleotide synthesis. It features a purine base with an isobutyramide protecting group and a dimethoxytrityl (DMT) protecting group on the sugar moiety, which is typical for solid-phase DNA/RNA synthesis.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 114745-26-5
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)guanosine
nucleoside analog pharmaceutical intermediate
5'-O-DMT-2'-O-iBu-N-Bz-Guanosine
protected guanosine for oligonucleotide synthesis
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
Pharmaceutical intermediate for oligonucleotide synthesis
Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-N-(2-methyl-1-oxopropyl)-
Protected nucleotide building block for oligonucleotide synthesis
[1,1'-Biphenyl]-2-carboxylic acid, 4'-methyl-, methyl ester
pharmaceutical intermediate
Methyl 4'-(Bromomethyl)biphenyl-2-carboxylate
pharmaceutical intermediate
TERT-BUTYL 4'-(BROMOMETHYL)BIPHENYL-2-CARBOXYLATE
pharmaceutical intermediate
2-Cyano-4'-methylbiphenyl
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
ISQLJOGRNUQHJX-WIFIACMTSA-N
CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OC